Literature DB >> 12969017

Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.

Arto Kokkola1, Timo U Kosunen, Pauli Puolakkainen, Pentti Sipponen, Matti Harkonen, Frank Laxen, Jarmo Virtamo, Reijo Haapiainen, Hilpi Rautelin.   

Abstract

Background. Only a few reported studies focus on the natural history and course of advanced and severe chronic atrophic gastritis. Methods. In this study we followed 47 men (mean age 62 years) with advanced (moderate or severe) Helicobacter pylori-positive atrophic corpus gastritis. Duration of endoscopic follow-up was 6 years and follow-up based on serum levels of pepsinogen I and antibodies to H. pylori covered a period of 10 years. None of the patients was treated for H. pylori infection prior to end of follow-up. Results. The median H. pylori antibody titre declined (IgG from 4000 to 1300; IgA from 200 to 50) in the study population, and 11 men (23%) converted to seronegative (p=0.0005, Fisher's exact test). There was a small but significant (p=0.0004, Page's test) declining trend in mean atrophy score of the corpus during follow-up (from 2.5 to 2.2). However, no significant changes were observed in grade of atrophy or intestinal metaplasia of the antral mucosa or in grade of intestinal metaplasia in the corpus. The mean SPGI level remained at the initial low level during the entire follow-up. Conclusions. H. pylori antibodies disappear spontaneously within 10 years in almost one fourth of patients with advanced atrophic corpus gastritis. The disappearance of H. pylori antibodies is accompanied by no or more than a mild improvement of the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969017     DOI: 10.1034/j.1600-0463.2003.1110604.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  44 in total

1.  Screening for early gastric cancer.

Authors:  K E L McColl
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Motor fluctuations and Helicobacter pylori in Parkinson's disease.

Authors:  Karl-Erik Rahne; Carl Tagesson; Dag Nyholm
Journal:  J Neurol       Date:  2013-09-04       Impact factor: 4.849

3.  Poor sensitivity of the signify H. pylori test.

Authors:  Vui Heng Chong
Journal:  Curr Microbiol       Date:  2008-10-02       Impact factor: 2.188

4.  Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk.

Authors:  Tomomitsu Tahara; Sayumi Tahara; Tetsuya Tuskamoto; Noriyuki Horiguchi; Dai Yoshida; Tomohiko Kawamura; Masaaki Okubo; Mitsuo Nagasaka; Yoshihito Nakagawa; Makoto Urano; Makoto Kuroda; Tomoyuki Shibata; Naoki Ohmiya
Journal:  Dig Dis Sci       Date:  2017-07-12       Impact factor: 3.199

5.  Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals.

Authors:  H J Windle; Y S Ang; V Athie-Morales; V A Morales; R McManus; D Kelleher
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Gastric adenocarcinoma in Zambia: a case-control study of HIV, lifestyle risk factors, and biomarkers of pathogenesis.

Authors:  V Kayamba; A W Asombang; V Mudenda; M M Lisulo; E Sinkala; S Mwanamakondo; I Mweemba; P Kelly
Journal:  S Afr Med J       Date:  2013-02-19

7.  Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.

Authors:  Arto Kokkola; Johanna Louhimo; Pauli Puolakkainen; Henrik Alfthan; Caj Haglund; Hilpi Rautelin
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Risk factors for gastric cancer in Latin America: a meta-analysis.

Authors:  Patricia Bonequi; Fernando Meneses-González; Pelayo Correa; Charles S Rabkin; M Constanza Camargo
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

9.  Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer.

Authors:  M Constanza Camargo; Kyoung-Mee Kim; Keitaro Matsuo; Javier Torres; Linda M Liao; Douglas R Morgan; Angelika Michel; Tim Waterboer; Jovanny Zabaleta; Ricardo L Dominguez; Yasushi Yatabe; Sung Kim; Erick R Rocha-Guevara; Jolanta Lissowska; Michael Pawlita; Charles S Rabkin
Journal:  Helicobacter       Date:  2015-08-07       Impact factor: 5.753

Review 10.  Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.

Authors:  David Y Graham; Masahiro Asaka
Journal:  J Gastroenterol       Date:  2009-08-28       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.